|Year : 2023 | Volume
| Issue : 1 | Page : 29-33
Bioactive phytoconstituents of ethanolic extract from Chromolaena odorata leaves interact with vascular endothelial growth factor and cyclooxygenase-2: A molecular docking study
TR Teuku Husni1, Darmawi Darmawi2, Azwar Azwar3, Kurnia Fitri Jamil4
1 Graduate School of Mathematics and Applied Sciences, Banda Aceh, Indonesia
2 Laboratory of Microbiology, Faculty of Veterinary Medicine, Banda Aceh, Indonesia
3 Departement of Ear, Nose, Throat, Head and Neck Surgery, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia
4 Departement of Internal Medicine, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia
|Date of Submission||07-Aug-2022|
|Date of Decision||19-Sep-2022|
|Date of Acceptance||26-Sep-2022|
|Date of Web Publication||20-Jan-2023|
Prof. Kurnia Fitri Jamil
Department of Internal Medicine, Faculty of Medicine, Universitas Syiah Kuala, Jl. T. Abe, Darussalam, Banda Aceh, Aceh - 23111
Source of Support: None, Conflict of Interest: None
Chromolaena odorata is an invasive plant with a broad spectrum of medicinal properties, including wound healing. This study aimed to evaluate the interaction of the already identified bioactive phytoconstituents from ethanolic extracts of C. odorata leaves with two angiogenesis-related proteins – vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) in silico. A molecular docking protocol was performed on AutoDock Vina employing the molecular structure of VEGF (3HNG) and COX-2 (3LN1) downloaded from the Protein Data Bank. The results reveal that most of the phytoconstituents possess strong binding affinity, where β-tocopherol and squalene have the highest values. In conclusion, it is highly possible that the phytoconstituents of C. odorata from the ethanolic leaf extract perform an interaction with VEGF and COX-2 and affect their activities.
Keywords: In silico, phytocompound, squalene, wound healing, β-tocopherol
|How to cite this article:|
Teuku Husni T R, Darmawi D, Azwar A, Jamil KF. Bioactive phytoconstituents of ethanolic extract from Chromolaena odorata leaves interact with vascular endothelial growth factor and cyclooxygenase-2: A molecular docking study. J Adv Pharm Technol Res 2023;14:29-33
|How to cite this URL:|
Teuku Husni T R, Darmawi D, Azwar A, Jamil KF. Bioactive phytoconstituents of ethanolic extract from Chromolaena odorata leaves interact with vascular endothelial growth factor and cyclooxygenase-2: A molecular docking study. J Adv Pharm Technol Res [serial online] 2023 [cited 2023 Mar 31];14:29-33. Available from: https://www.japtr.org/text.asp?2023/14/1/29/368247
| Introduction|| |
An invasive weed, Chromolaena odorata, has attracted the attention of phytomedicine experts due to its richness in bioactivities. A review article from 2021 has highlighted several common bioactivities of this plant including anti-inflammatory, antiparasitic, antimicrobial, anticancer, antidiabetic, antipyretic, antinociceptive, and wound healing. Among its vast medicinal benefits, the wound-healing properties of this plant are considered promising. The first report of the wound-healing potential of C. odorata could be traced back to as early as 1998, where a study observed the increased growth of fibroblasts and endothelial cells upon exposure to aqueous extract of C. odorata leaves. More recently, researchers have now focused on identifying its phytocompounds and wound-healing mechanisms., Some studies even have used the C. odorata extracts as active agents in topical gel formulations., Since the phytoconstituents of this plant have strong antioxidant activities, many reports suggest the involvement of oxidative stress attenuation as the main mechanism of its wound-healing activities.
Wound healing involves four major steps including coagulation and homeostasis, inflammation, proliferation, and tissue remodeling. C. odorata is prominent in facilitating proliferation steps, especially by promoting angiogenesis, cell adhesion, and fibroblast proliferation., In this step, vascular endothelial growth factor (VEGF) and cyclooxygenase (COX-2) work collectively or independently in inducing inflammation response, angiogenesis, and re-epithelization. VEGF in particular has the ability to stimulate vasculogenesis, induce inflammation, and control vascular permeability. Meanwhile, COX-2 is upregulated in almost all tissue injuries and produces prostaglandins through arachidonic acid conversion. Particular COX-2 inhibitors have been shown to promote cutaneous wound healing which was observed along with decreased expression of inducible nitric oxide synthase. Increased COX-2 levels were documented to be affected by VEGF concentration in endothelial cells. Therefore, in this study, we determined the interaction between VEGF or COX-2 and phytoconstituents from C. odorata. Molecular docking was used as a modality to investigate the interactions by providing data on binding affinity and the most probable binding locations. The rationale for using molecular docking was its accuracy in predicting the ligand–protein interaction without the necessity of consuming a lot of resources.,
| Materials and Methods|| |
The leaves of C. odorata were collected from Darussalam, Banda Aceh, Indonesia on May 10, 2021. The plant was identified for its taxonomy at the Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Indonesia on October 20, 2021, by Dr. Rasnovi (voucher number: 559/UN188.8.131.52/TA.00.01/2021).
Selection of ligands
Phytoconstituents were identified using gas chromatography–mass spectrometry (GC-MS) in the ethanolic extract from C. odorata leaves which were collected from Darussalam, Banda Aceh, Indonesia. The extraction procedure followed the suggestion from previously reported studies. Briefly, crushed dried leaves were macerated using ethanol 70% for 24 h before the filtrate was collected and subsequently concentrated using a rotary evaporator. The extract was analyzed using GC-MS (QP2010 SE, Shimadzu, Kyoto, Japan) and each of the identified phytoconstituents was screened in silico for its bioactivities. Detailed characteristics of each phytoconstituent, including its chemical formula, are presented in [Table 1]. LogP, the number of hydrogen bond acceptors (nON), as well as the number of hydrogen bond donors (nOHNH) were estimated from the algorithm used by Molinspiration (https://www.molinspiration.com/). For the molecular docking study, the 3D structure of each phytoconstituent was downloaded from PubChem (https://pubchem. ncbi.nlm.nih.gov/). The ligand molecule was reformatted from.sdf to.pdb and added with hydrogens using Chimera 1.15.
|Table 1: Molecular characteristics of the phytoconstituents identified in the ethanolic extract from Chromolaena odorata leaves|
Click here to view
Protein molecule acquisition and preparation
The molecular docking was performed on hardware with the following specifications: random access memory of 4 GB, 64-bit operating system, and Windows 10 operating system. Molecular structures of VEGF (3HNG) and COX-2 (3 LN1) were acquired from the Protein Data Bank (PDB, https://www.rcsb.org/). Threading of the foregoing structures was performed on Iterative Threading ASSEmbly Refinement. The protein structures were prepared using Chimera 1.15 to remove solvents and native ligands and to be fixed for missing amino atoms.
Molecular docking and visualization
Ligand docking onto the protein molecule was performed on AutoDock Vina 1.1.2 following the suggestions from a published report. Priorly, all.pdb files were converted into.pdbqt using AutoDockTools. Gridbox size and position were adjusted according to the biggest tested ligand molecule and native ligand, respectively. The exhaustiveness was adjusted to 8. After the docking was performed, ligand–protein interaction was visualized on BIOVIA Discovery Studio Visualizer 21.1. To validate the docking procedure, the native ligand was redocked onto its protein molecule, where the root-mean-square deviation value was found below 2.
| Results and Discussion|| |
Molecular characteristics of the phytoconstituents
Molecular characteristics of bioactive phytoconstituents of ethanolic extract from C. odorata leaves are presented in [Table 1]. Molecular weight, LogP value, nON, and nOHNH, according to Lipinski's rule of five, should be below or equal to 500 g/mol, 5, 10, and 5, respectively. Herein, the violation was only found in terms of the LogP value (>5), as shown by phytyl acetate, pentadecadien-1-ol, octadecanoic acid, squalene, β-tocopherol, and octacosanol. Violation of this rule suggests the poor bioavailability and absorption of the foregoing phytocompounds.
Molecular docking results of the phytoconstituents onto the molecular structure of VEGF and COX-2 are presented in [Table 2]. β-tocopherol appeared to have the highest affinity with VEGF or COX-2, followed by squalene. The binding affinity of β-tocopherol with VEGF and COX-2 were − 13.63 and −16.66 kcal/mol, respectively. Hydrogen bond contributes to that value was located at Asp1040 and Gln178, for VEGF and COX-2, respectively. In the case of squalene, the value was lower, where its binding affinity with VEGF and COX-2 was observed to be −11.93 and −14.50 kcal/mol, respectively, without involving a hydrogen bond. Both β-tocopherol and squalene had stronger affinities with VEGF or COX-2, as compared with the native ligand. In comparison, binding affinity >5 kcal/mol is usually used as an indication of the ligand's capability in forming an interaction with the protein.,
|Table 2: Molecular docking parameters obtained from the interaction between the phytoconstituents (ligand) and vascular endothelial growth factor or cyclooxygenase-2 (receptor)|
Click here to view
The locations of interaction formed between the ligand and protein could be observed in 3D or 2D illustration [Figure 1]. The native ligand of VEGF binds tightly at Cys912, Glu878, and Asp1040. Meanwhile, in the case of COX-2, the strong binding of the native ligand occurred at Ser339, Gln178, and Leu338. Interestingly, β-tocopherol appears to form hydrogen bonds at Asp1040 and Gln178 which are the catalytic sites of VEGF and COX-2, respectively. It suggests the possibility of β-tocopherol acting as an inhibitor through substrate blockage. Even though squalene occupies noncatalytic parts of the protein, with such a strong binding affinity, it could inhibit or increase the activity of the proteins. Taken altogether, β-tocopherol and squalene may affect the activities of VEGF or COX-2 since their binding affinities are high.
|Figure 1: Visualization of molecular interactions of the Chromolaena orodata phytoconstituents with VEGF (a) and COX-2 (b). The phytoconstituents are ledol squalene, β-tocopherol, and octacosanol. VEGF: Vascular endothelial growth factor, COX-2: Cyclooxygenase-2|
Click here to view
The interactions of β-tocopherol and squalene as the phytoconstituents of C. odorata could be responsible for the therapeutical properties of the ethanolic leaf extract. The ability of the C. odorata extract in assisting wound recovery could be derived from its anti-inflammation activities and ability to enhance mature tissue granulation through protein signaling. COX-2 and VEGF have activities that could induce the inflammation occurred during tissue injuries. Meanwhile, the foregoing interaction formed by the presence of C. orodata phytoconstituents could assist the epithelization and collagen deposition during angiogenesis.
| Conclusion|| |
Our molecular docking analysis reveals the strong interaction between the phytoconstituents of C. odorata leaf (particularly, β-tocopherol and squalene) and VEGF or COX-2. β-tocopherol may act as a blockage to VEGF and COX-2 since the hydrogen bonds are formed at the active sites. Squalene, another phytoconstituent with high binding affinities, may inhibit the protein activities by acting as a noncompetitive pathway or increase the activities by stabilizing the proteins' molecules. Since both β-tocopherol and squalene have a violation of Lipinski's rule of five, their development as drug candidates should involve an adequate drug delivery system. In vitro and in vivo investigations on C. odorata leaf extract as a wound-healing agent are warranted in future research.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Olawale F, Olofinsan K, Iwaloye O. Biological activities of chromolaena odorata: A mechanistic review. S Afr J Bot 2022;144:44-57.
Phan TT, Hughes MA, Cherry GW. Enhanced proliferation of fibroblasts and endothelial cells treated with an extract of the leaves of Chromolaena odorata
(Eupolin), an herbal remedy for treating wounds. Plast Reconstr Surg 1998;101:756-65.
Vijayaraghavan K, Rajkumar J, Seyed MA. Phytochemical screening, free radical scavenging and antimicrobial potential of Chromolaena odorata
leaf extracts against pathogenic bacterium in wound infections – A multispectrum perspective. Biocatal Agric Biotechnol 2018;15:103-12.
Thang PT, Patrick S, Teik LS, Yung CS. Anti-oxidant effects of the extracts from the leaves of Chromolaena odorata
on human dermal fibroblasts and epidermal keratinocytes against hydrogen peroxide and hypoxanthine-xanthine oxidase induced damage. Burns 2001;27:319-27.
Yudhika I, Jailani M, Dasrul D. Histopathological overview of wound healing process in white rats (Rattus norvegicus
) using Chromolaena odorata
leaf jelly extract. J Int Surg Clin Med 2021;1:21-8.
Zamram QA, Mohsin HF, Mohamad M, Nor Hazalin NA, Hamid KA. Physical Characterisation and stability study of formulated Chromolaena odorata
gel. Curr Drug Deliv 2022;19:479-90.
Futagami A, Ishizaki M, Fukuda Y, Kawana S, Yamanaka N. Wound healing involves induction of cyclooxygenase-2 expression in rat skin. Lab Invest 2002;82:1503-13.
Oberyszyn TM. Inflammation and wound healing. Front Biosci 2007;12:2993-9.
Romana-Souza B, Santos JS, Bandeira LG, Monte-Alto-Costa A. Selective inhibition of COX-2 improves cutaneous wound healing of pressure ulcers in mice through reduction of iNOS expression. Life Sci 2016;153:82-92.
Akarasereenont PC, Techatraisak K, Thaworn A, Chotewuttakorn S. The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase. Mediators Inflamm 2002;11:17-22.
Purnama A, Mardina V, Puspita K, Qanita I, Rizki DR, et al
. Molecular docking of two cytotoxic compounds from Calotropis gigantea
leaves against therapeutic molecular target of pancreatic cancer. Narra J 2021;1:e37.
Purnama A, Rizki DR, Qanita I, Iqhrammullah M, Ahmad K, Mardina V, et al.
Molecular docking investigation of calotropone as a potential natural therapeutic agent against pancreatic cancer. J Adv Pharm Technol Res 2022;13:44-9. [Full text]
Hasballah K, Sarong M, Rusly R, Fitria H, Maida DR, Iqhrammullah M. Antiproliferative activity of triterpenoid and steroid compounds from ethyl acetate extract of Calotropis gigantea
root bark against P388 Murine Leukemia cell lines. Sci Pharm 2021;89:21.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3-26.
Madej T, Lanczycki CJ, Zhang D, Thiessen PA, Geer RC, Marchler-Bauer A, et al.
MMDB and VAST+: Tracking structural similarities between macromolecular complexes. Nucleic Acids Res 2014;42:D297-303.
Wang JL, Limburg D, Graneto MJ, Springer J, Hamper JR, Liao S, et al.
The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life. Bioorg Med Chem Lett 2010;20:7159-63.
Santos T, Lopes-Nunes J, Alexandre D, Miranda A, Figueiredo J, Silva MS, et al.
Stabilization of a DNA aptamer by ligand binding. Biochimie 2022;200:8-18.
Mokhtar NA, Tap FM, Talib SZ, Khairudin NA. Docking study for assessment of wound healing potential of isosakuratenin isolated from Chromolaena odorata
: An in-silico
approach. IOP Conf Ser Mater Sci Eng 2021;1051:012078.
Smith GA, Fearnley GW, Tomlinson DC, Harrison MA, Ponnambalam S. The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis. Biosci Rep 2015;35:e00253.
[Table 1], [Table 2]